2025-05-30 - Analysis Report
Okay, here's the analysis of Albemarle Corp (ALB) based on the provided data, presented in English with concise explanations:

**Report on Albemarle Corp (ALB)**

**1. Performance vs. S&P 500 (VOO)**

*   **Ticker:** ALB
*   **Company Description:** Albemarle Corp is a specialty chemicals company with leading positions in lithium, bromine, and catalysts.

*   **Cumulative Return (ALB):** 0.89%
*   **Cumulative Return (VOO):** 82.09%
*   **Absolute Divergence:** -81.2
*   **Relative Divergence:** 0.1

**Analysis:** ALB has significantly underperformed the S&P 500 (VOO) based on cumulative returns. The relative divergence of 0.1 indicates ALB is near the bottom end of its historical performance range relative to VOO.

**Alpha, Beta Analysis:**

| Year       | CAGR    | MDD    | Alpha   | Beta | Cap(B) |
|------------|---------|--------|---------|------|--------|
| 2015-2017  | 99.0%   | 7.7%   | 70.0%   | 0.0  | 13.8   |
| 2016-2018  | 13.0%   | 58.1%  | -5.0%   | 0.0  | 8.4    |
| 2017-2019  | -45.0%  | 58.1%  | -74.0%  | -0.0 | 8.2    |
| 2018-2020  | 101.0%  | 62.9%  | 75.0%   | 0.7  | 16.8   |
| 2019-2021  | 268.0%  | 62.9%  | 214.0%  | 0.8  | 26.8   |
| 2020-2022  | 239.0%  | 75.8%  | 233.0%  | 1.1  | 25.0   |
| 2021-2023  | -53.0%  | 77.6%  | -69.0%  | 0.6  | 16.8   |
| 2022-2024  | -204.0% | 77.6%  | -221.0% | 0.8  | 10.2   |
| 2023-2025  | -347.0% | 77.6%  | -377.0% | 3.4  | 6.8    |

**Analysis:** The table reveals fluctuating performance. While some periods show high CAGR and Alpha, recent years exhibit significant negative returns, high Maximum Drawdown (MDD), and negative Alpha. The Beta values have increased over time. Capitalization (Cap) has decreased from 2021-2025 period.

**2. Recent Stock Price Movement**

*   **Last Price:** 57.49
*   **Previous Close:** 58.05
*   **Change:** -0.96

*   **5-day Moving Average:** 57.976
*   **20-day Moving Average:** 58.82
*   **60-day Moving Average:** 63.8928

**Analysis:** The stock price has decreased slightly. The price is below all moving averages, indicating a potential downtrend. The last price change is negative but not drastic, suggesting a moderate downward pressure.

**3. Indicators & Expected Return**

*   **Market Risk Indicator (MRI):** 0.366 (Low Risk)
*   **RSI:** 50.17 (Neutral)
*   **PPO:** 0.1547 (Slightly Bullish)
*   **Hybrid Signal:** cash_0%_Buy 80% of cash (1 shares - Caution - MRI:0.38)
*   **Delta_Previous_Relative_Divergence:** 0.1 (+) (Short-term increase)
*   **Expected Return (%):** 13190.0

**Analysis:** The MRI indicates low market risk. The RSI is neutral, suggesting neither overbought nor oversold conditions. The PPO is slightly bullish.  The recent increase in relative divergence suggests a short-term upward trend. However, the last price change is negative and could be considered a signal.

**4. Recent News & Significant Events**

*   **2025-05-28:** Business developments, regulatory changes, or market events.
*   **2025-05-29:** Analyst discussions on recent performance and industry trends.
*   **2025-05-26:** Stock volatility influenced by news, earnings, or executive actions.
*   **2025-05-30:** Market experts highlight risks and opportunities.

**Analysis:** Recent news suggests ALB is experiencing volatility and is subject to market scrutiny. Investors should monitor news and company announcements closely.

**5. Recent Earnings Analysis**

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-04-30 | 0    | 1.08 B$  |
| 2024-11-06 | -9.45 | 1.35 B$  |
| 2024-07-31 | -1.96 | 1.43 B$  |
| 2024-05-01 | -0.08 | 1.36 B$  |
| 2025-04-30 | -0.08 | 1.36 B$  |

**Analysis:** The recent earnings data shows a concerning trend. While revenue has fluctuated, EPS has been mostly negative, indicating profitability issues. The significant negative EPS in 2024-11-06 is particularly noteworthy.

**6. Financial Information**

**Revenue and Profitability:**

| Quarter      | Revenue    | Profit Margin |
|--------------|------------|---------------|
| 2025-03-31 | $1.08B     | 14.51%        |
| 2024-12-31 | $1.23B     | 11.22%        |
| 2024-09-30 | $1.35B     | -7.68%        |
| 2024-06-30 | $1.43B     | -0.74%        |
| 2024-03-31 | $1.36B     | 2.86%         |

**Capital and Profitability:**

| Quarter      | Equity     | ROE        |
|--------------|------------|------------|
| 2025-03-31 | $10.03B    | 0.41%      |
| 2024-12-31 | $9.96B    | 0.76%      |
| 2024-09-30 | $10.24B    | -10.44%     |
| 2024-06-30 | $11.22B    | -1.68%     |
| 2024-03-31 | $11.53B    | 0.02%      |

**Analysis:** Revenue has generally declined over the past year. Profit margins were negative in two quarters. Equity has also decreased, and ROE has been low or negative in several quarters, suggesting challenges in generating returns on equity.

**7. Overall Analysis**

Albemarle Corp (ALB) is currently facing several challenges. It has significantly underperformed the S&P 500. Recent earnings and financial data reveal declining revenue, negative profit margins, and negative EPS. Recent news highlights volatility and market scrutiny. While the MRI indicates low market risk and the PPO is slightly bullish, the overall picture suggests caution. The recent short-term increase in relative divergence and the high expected return should be viewed with skepticism given the other negative indicators. Investors should carefully monitor upcoming news and earnings releases.
